First-generation genomic tests for breast cancer treatment

Lancet Oncol. 2010 Jan;11(1):6-7. doi: 10.1016/S1470-2045(09)70347-X. Epub 2009 Dec 10.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / genetics*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / secondary
  • Cyclophosphamide / therapeutic use
  • Disease-Free Survival
  • Doxorubicin / therapeutic use
  • Female
  • Fluorouracil / therapeutic use
  • Gene Expression Profiling*
  • Gene Expression Regulation, Neoplastic*
  • Genetic Testing / methods*
  • Humans
  • Lymphatic Metastasis
  • Predictive Value of Tests
  • Receptors, Estrogen / analysis
  • Recurrence
  • Tamoxifen / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Receptors, Estrogen
  • Tamoxifen
  • Doxorubicin
  • Cyclophosphamide
  • Fluorouracil

Supplementary concepts

  • CAF protocol